Safety of long-acting β-agonists

被引：12

作者：

Nelson, Harold S. ^{[1
]}

Dorinsky, Paul M.

机构：

[1] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA

[2] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2006年 / 145卷 / 09期

关键词：

D O I：

10.7326/0003-4819-145-9-200611070-00017

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：706 / 706

页数：1

共 9 条

[1]

*AM LUN ASS EP SAT, 2006, TRENDS ASTHM MORB MO

[2] Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].

Bateman, ED ;

Boushey, HA ;

Bousquet, J ;

Busse, WW ;

Clark, TJH ;

Pauwels, RA ;

Pedersen, SE .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844

[3]

Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1

[4] Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma [J].

Masoli, M ;

Weatherall, M ;

Holt, S ;

Beasley, R .

THORAX, 2005, 60 (09) :730-734

[5] Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations [J].

Matz, J ;

Emmett, A ;

Rickard, K ;

Kalberg, C .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (05) :783-789

[6]

MININO, 2006, NATL VITAL STAT REP, V54, P1

[7]

Ni CM, 2005, COCHRANE DB SYST REV

[8] Meta-analysis:: Effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths [J].

Salpeter, Shelley R. ;

Buckley, Nicholas S. ;

Ormiston, Thomas M. ;

Salpeter, Edwin E. .

ANNALS OF INTERNAL MEDICINE, 2006, 144 (12) :904-912

[9] Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA) [J].

Shrewsbury, S ;

Pyke, S ;

Britton, M .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7246) :1368-1373

← 1 →